Help researchers crack the code! Sign up for Epidemiology of Young Lung Cancer. More research + more knowledge leads to new treatments and a cure.
Posts in the “Featured LinksFeatured Links Archives - ALCMI - Addario Lung Cancer Medical Institute” category:
Genomics of Young Lung Cancer ALCMI Study Published
ALCMI’s GOYLC study has been published in JTO Clinical and Research Reports. Click here to read the full text article.
First Patient Enrolled in Biodesix and Addario Lung Cancer Medical Institute Study Aiming to Predict Patient Survival Using a Blood-based Biomarker
Study will evaluate the use of a blood-based biomarker to predict outcomes in high PD-L1 expressing non-small cell lung cancer patients treated with immune checkpoint inhibitors plus or minus chemotherapy
Epidemiology of Young Lung Cancer
This study seeks to help better understand why an increasing number of young people are developing lung cancer. Specifically, we are looking to study the environmental and childhood exposures, and other risk factors for lung cancer in persons under age 40.
SPACEWALK – A Study for Patients with ALK Drug Resistance
This study seeks to better understand this kind of cancer and to develop new future lung cancer treatments. Specifically, we are looking for genetic changes in the ALK gene that could help to understand why a cancer has developed drug resistance.
Genomics of Young Lung Cancer and INHERIT Studies Accepted for Presentation at ASCO
Two Addario Lung Cancer Medical Institute research studies funded in part by the Bonnie J. Addario Lung Cancer Foundation chosen for presentation at the May/June 2015 American Society of Clinical Oncology Annual Meeting
International Partnership to Address Lung Cancer Epidemic
According to a recent study in the Annals of Oncology, lung cancer fatalities are set to overtake breast cancer deaths among European women for the first time this year. It is predicted lung cancer deaths for women in Europe will reach 14.24 per 100,000 of the population in 2015.
ALCMI Launches Genomics of Young Lung Cancer Study
The Addario Lung Cancer Medical Institute (ALCMI) today launched a new study, the Genomics of Young Lung Cancer, to understand why lung cancer occurs in young adults, who quite often are athletic, never smokers and do not exhibit any of the known lung cancer genetic mutations.
Exosome Diagnostics & ALCMI Announce Collaboration on Sequencing Blood
CAMBRIDGE, Mass. and LOS ANGELES, Calif., Jan. 9, 2015 – Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced a strategic collaboration with the Addario Lung Cancer Medical Institute (ALCMI) to accelerate the development of its lead plasma-based diagnostics in development for mutation detection and monitoring in patients with lung cancer. The […]